Search results
Results from the WOW.Com Content Network
Cathay Drug is recognized as one of the fastest-growing pharmaceutical companies in the Philippines. In 2012, it was included in the Top 20 Leading Philippine Pharmaceutical Companies based on Value in the Philippine Pharmaceutical Industry Audit [2] for ethical segment by IMS. It was also ranked second among national pharmaceutical companies ...
Unilab, Inc., commonly known as Unilab (stylized in all caps), is a Philippine pharmaceutical company headquartered in Mandaluyong, Metro Manila. [1] It specializes in a wide range of consumer healthcare products such as prescription and over-the counter medications, vitamins and food supplements, and biotechnology.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
For one, by 2030, the pharma industry could be worth nearly $1.6 trillion, according to Acumen Research and Consulting. Two, the best pharma stocks are still ranked as some of the safest ...
The top 16 best selling pharmaceuticals of 2017/18. [2] Rank Drug Main indication Trade name 2018 sales (million USD) 2017 sales (million USD) 1 adalimumab:
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Pages in category "Pharmaceutical companies of the Philippines" The following 3 pages are in this category, out of 3 total. This list may not reflect recent changes. C.
If you want to see more stocks in this selection, check out 5 Best Pharma Dividend Stocks To Buy. As per a Bloomberg report dated September 12, the global bio-pharma market was valued at $274.10 ...